A Randomised Controlled Trial of High Dose, Inhaled Budesonide Versus Oral Prednisone in Patients Discharged from the Emergency Department following an Acute Asthma Exacerbation
OBJECTIVE: Prednisone (PRED) is recommended at discharge to reduce the relapse rate following emergency treatment for an asthmatic attack. However, PRED has systemic side effects. Inhaled anti-inflammatory medications, such as budesonide (BUD), are well tolerated. This study was designed to compare...
Main Authors: | J Mark FitzGerald, David Shragge, Jennifer Haddon, Barbara Jennings, Joanna Lee M Math, Tony Bai, Peter Pare, David Kassen, Anton Grunfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2000-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2000/587957 |
Similar Items
-
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
by: Halpin David MG, et al.
Published: (2006-06-01) -
Comparison of Budesonide Turbuhaler with Budesonide Aqua in the Treatment of Seasonal Allergic Rhinitis
by: William H Yang, et al.
Published: (1998-01-01) -
Hypersensitivity with Inhalational Budesonide: An Under Recognised Entity
by: Pramod Kumar Sharma, et al.
Published: (2016-10-01) -
Discharge Considerations for Adult Asthmatic Patients Treated in Emergency Departments
by: Anton F Grunfeld, et al.
Published: (1996-01-01) -
Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
by: Arun Jenish J, et al.
Published: (2012-03-01)